Biguanide

Metformin

Buformin

Phenformin

Biguanides are a class of chemical compounds and medications characterized by the presence of two guanidine groups. They are widely used in medicine, particularly for the treatment of diabetes mellitus type 2, as they help to lower blood sugar levels by reducing the amount of glucose produced by the liver, increasing the insulin sensitivity of body tissues, and reducing the amount of glucose absorbed by the intestines.

History[edit | edit source]

The use of biguanides can be traced back to the use of the plant Galega officinalis (French lilac, also known as goat's rue), which was used in medieval Europe to treat symptoms of what is now known to be diabetes mellitus. The active ingredient in this plant, galegine, shares a similar structure and pharmacological properties with modern biguanides. The development of synthetic biguanides began in the 20th century, leading to the introduction of phenformin and buformin, both of which were eventually withdrawn from many markets due to their association with lactic acidosis. Metformin, the most widely used biguanide, was developed in the 1950s and has become the first-line treatment for type 2 diabetes due to its efficacy and safety profile.

Mechanism of Action[edit | edit source]

Biguanides primarily work by inhibiting gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate sources. This leads to a decrease in hepatic glucose output. Additionally, they improve insulin sensitivity, which enhances peripheral glucose uptake and utilization. Unlike some other diabetes medications, biguanides do not increase insulin secretion and therefore do not cause hypoglycemia when used alone.

Clinical Uses[edit | edit source]

The primary clinical use of biguanides is in the management of type 2 diabetes. Metformin, in particular, is recommended as the first-line pharmacological treatment for most patients with this condition. It is often prescribed in combination with other antidiabetic medications or insulin to achieve better glucose control. Beyond diabetes management, metformin has been studied for its potential benefits in conditions such as polycystic ovary syndrome (PCOS), weight management, and possibly some forms of cancer, although its use in these areas is less established.

Adverse Effects[edit | edit source]

While biguanides are generally well tolerated, they can cause side effects in some individuals. The most common adverse effect is gastrointestinal discomfort, including nausea, vomiting, diarrhea, and abdominal pain. These symptoms are usually transient and can be minimized by taking the medication with food and starting with a low dose that is gradually increased. A more serious but rare side effect is lactic acidosis, a condition characterized by the buildup of lactic acid in the body, which can be fatal if not treated promptly. The risk of lactic acidosis is higher in patients with kidney disease, liver disease, and those with conditions that predispose to tissue hypoxia.

Conclusion[edit | edit source]

Biguanides, particularly metformin, play a crucial role in the management of type 2 diabetes and have potential applications in other medical conditions. Their mechanism of action, which includes the inhibition of hepatic glucose production and improvement of insulin sensitivity, makes them an effective option for controlling blood glucose levels without the risk of hypoglycemia. Despite their benefits, the potential for adverse effects, especially gastrointestinal issues and the rare risk of lactic acidosis, necessitates careful patient selection and monitoring.